Home » Topics » BioWorld

BioWorld
RSS

SERAGEN REPORTS FUSION TOXIN DATA

Nov. 18, 1992

HIRULOG SAFE AND EFFECTIVE IN TRIAL

Nov. 18, 1992

EX-PRESIDENT SETTLES WITH PERSEPTIVE

Nov. 18, 1992

ISIS BEGINS TRIALS FOR ANTISENSE DRUG

Nov. 18, 1992

CHALLENGE OF DELIVERING DRUGS ORALLY

Nov. 18, 1992

GENSET RAISES $7 MILLION

Nov. 18, 1992

ENCOURAGING DATA FROM SERAGEN'S IL-2

Nov. 17, 1992

LIFECORE STOCK UP 25 PERCENT

Nov. 17, 1992

LIPOSOME TECH. PRODUCES AMPHOCIL FOR TRIALS

Nov. 17, 1992

DYNAGEN'S TEST IDENTIFIES ACTIVE TB

Nov. 17, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026